Literature DB >> 30300287

Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.

Irene Pierantonelli1, Gianluca Svegliati-Baroni1,2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) represents a growing cause of chronic liver injury, especially in western countries, where it is becoming the most frequent indication for liver transplantation. Nonalcoholic fatty liver disease encompasses a spectrum of diseases that from simple steatosis (pure NAFLD) can progress to nonalcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma. The pathogenesis of NAFLD and the mechanisms behind its progression to NASH have been extensively studied. However, although the processes that determine fat accumulation are mostly clear, the mechanisms associated with the progression of the disease are not fully characterized. In predisposed patients, lipid accumulation can promote lipotoxicity and mitochondrial dysfunction, thus triggering hepatocyte death, inflammation and fibrosis. The specific role of different lipids has been identified and free fatty acids as well as free cholesterol have been identified as toxic species. To make the picture more complex, the pathogenesis of NAFLD involves pathological connections between several organs, including the adipose tissue and the gut, with the liver. The "inflamed" adipose tissue plays a key role in the release of toxic lipids, whereas alterations in the gut-liver axis have been associated with the progression from NAFLD to NASH mediated by dysbiosis, alteration of intestinal barrier, and finally bacterial translocation, which can trigger proinflammatory and profibrogenetic pathways, finally leading to cirrhosis development.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30300287     DOI: 10.1097/TP.0000000000002480

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  76 in total

1.  Evaluating the effect of a mixture of two main conjugated linoleic acid isomers on hepatic steatosis in HepG2 cellular model.

Authors:  Ali Jalilian; Taghi Golmohammadi; Reza Meshkani; Mehdi Koushki; Neda Eivazi; Reyhaneh Babaei Khorzoughi; Seyed Reza Hosseini Fard; Maliheh Paknejad
Journal:  Mol Biol Rep       Date:  2021-02-12       Impact factor: 2.316

2.  Identification of transcriptomic signatures and crucial pathways involved in non-alcoholic steatohepatitis.

Authors:  Weiwei He; Caoxin Huang; Xiaofang Zhang; Dongmei Wang; Yinling Chen; Yan Zhao; Xuejun Li
Journal:  Endocrine       Date:  2021-04-10       Impact factor: 3.633

3.  The effects of high fructose fruits and honey on the serum level of metabolic factors and nonalcoholic fatty liver disease.

Authors:  Fatemeh Sadeghi; Sasan Amanat; Mohammad Bakhtiari; Hadis Asadimehr; Mohammad Ali Okhovat; Masood Hosseinzadeh; Seyed Mohammad Mazloomi; Maryam Gholamalizadeh; Saeid Doaei
Journal:  J Diabetes Metab Disord       Date:  2021-10-28

Review 4.  Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification.

Authors:  Saranya Chidambaranathan-Reghupaty; Paul B Fisher; Devanand Sarkar
Journal:  Adv Cancer Res       Date:  2020-11-28       Impact factor: 6.242

Review 5.  MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.

Authors:  Zhiqiang Fang; Guorui Dou; Lin Wang
Journal:  Int J Biol Sci       Date:  2021-04-29       Impact factor: 6.580

Review 6.  Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy.

Authors:  Jianan Zhao; Yiyang Hu; Jinghua Peng
Journal:  Cell Mol Biol Lett       Date:  2021-05-07       Impact factor: 5.787

Review 7.  Non-alcoholic fatty liver diseases: current challenges and future directions.

Authors:  Elke Roeb
Journal:  Ann Transl Med       Date:  2021-04

8.  16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome.

Authors:  Sitong Dong; Jiao Jiao; Shuangshuo Jia; Gaoyu Li; Wei Zhang; Kai Yang; Zhen Wang; Chao Liu; Da Li; Xiuxia Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-05-10       Impact factor: 5.293

9.  Transcranial direct current stimulation (tDCS) has beneficial effects on liver lipid accumulation and hepatic inflammatory parameters in obese rats.

Authors:  Larisse Longo; Valessa Emanoele Gabriel de Souza; Dirson João Stein; Joice Soares de Freitas; Carolina Uribe-Cruz; Iraci L S Torres; Mário Reis Álvares-da-Silva
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

10.  DHA Protects Hepatocytes from Oxidative Injury through GPR120/ERK-Mediated Mitophagy.

Authors:  Jinglong Chen; Danping Wang; Yibo Zong; Xiaojing Yang
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.